AR228442A1 - Procedimiento para la preparacion de 1-(8-quinolil)-2-pirrolidinona - Google Patents

Procedimiento para la preparacion de 1-(8-quinolil)-2-pirrolidinona

Info

Publication number
AR228442A1
AR228442A1 AR283420A AR28342080A AR228442A1 AR 228442 A1 AR228442 A1 AR 228442A1 AR 283420 A AR283420 A AR 283420A AR 28342080 A AR28342080 A AR 28342080A AR 228442 A1 AR228442 A1 AR 228442A1
Authority
AR
Argentina
Prior art keywords
pirrolidinone
quinolyl
procedure
preparation
Prior art date
Application number
AR283420A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of AR228442A1 publication Critical patent/AR228442A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AR283420A 1979-11-30 1980-11-28 Procedimiento para la preparacion de 1-(8-quinolil)-2-pirrolidinona AR228442A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941409 1979-11-30

Publications (1)

Publication Number Publication Date
AR228442A1 true AR228442A1 (es) 1983-03-15

Family

ID=10509524

Family Applications (1)

Application Number Title Priority Date Filing Date
AR283420A AR228442A1 (es) 1979-11-30 1980-11-28 Procedimiento para la preparacion de 1-(8-quinolil)-2-pirrolidinona

Country Status (18)

Country Link
US (1) US4366158A (es)
EP (1) EP0030023A3 (es)
JP (1) JPS5699475A (es)
KR (1) KR830004293A (es)
AR (1) AR228442A1 (es)
AT (1) AT375363B (es)
AU (1) AU6495080A (es)
CA (1) CA1156235A (es)
DK (1) DK506480A (es)
ES (1) ES497242A0 (es)
FI (1) FI803704L (es)
GB (1) GB2063868B (es)
GR (1) GR71918B (es)
HU (1) HU185224B (es)
IL (1) IL61580A (es)
IT (1) IT1221040B (es)
NZ (1) NZ195688A (es)
ZA (1) ZA807467B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000795A (es) 2003-07-22 2006-08-23 Arena Pharm Inc Derivados de diaril y arilheteroaril urea como moduladores del receptor 5-ht2a de serotonina utiles para la profilaxis y tratamiento de desordenes relacionados con el mismo.
GB0507198D0 (en) * 2005-04-08 2005-05-18 Sb Pharmco Inc Process for preparing bicyclic compounds
GB0519758D0 (en) * 2005-09-28 2005-11-09 Glaxo Group Ltd Novel process
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
EP4119141A1 (en) 2015-06-12 2023-01-18 Axovant Sciences GmbH Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder
CA2992518A1 (en) 2015-07-15 2017-01-19 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143151A (en) * 1978-07-03 1979-03-06 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids

Also Published As

Publication number Publication date
ES8203882A1 (es) 1982-04-01
IT8050277A0 (it) 1980-11-28
EP0030023A2 (en) 1981-06-10
GR71918B (es) 1983-08-17
US4366158A (en) 1982-12-28
ES497242A0 (es) 1982-04-01
KR830004293A (ko) 1983-07-09
IL61580A0 (en) 1980-12-31
HU185224B (en) 1984-12-28
ZA807467B (en) 1982-07-28
ATA582780A (de) 1983-12-15
IL61580A (en) 1984-06-29
IT1221040B (it) 1990-06-21
CA1156235A (en) 1983-11-01
JPS5699475A (en) 1981-08-10
AT375363B (de) 1984-07-25
AU6495080A (en) 1981-06-04
FI803704L (fi) 1981-05-31
GB2063868A (en) 1981-06-10
NZ195688A (en) 1984-09-28
GB2063868B (en) 1984-02-29
EP0030023A3 (en) 1981-09-02
DK506480A (da) 1981-05-31

Similar Documents

Publication Publication Date Title
ES497661A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
ES495034A0 (es) Procedimiento para la confeccion de protesis dentales
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
MX152233A (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493300A0 (es) Procedimiento para la preparacion de acilureas
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
AR228442A1 (es) Procedimiento para la preparacion de 1-(8-quinolil)-2-pirrolidinona
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
MX6327E (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden-hidrazinopiridazina
MX6151E (es) Procedimiento para la preparacion de 7-acilindolinas
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
AR223553A1 (es) Procedimiento para la preparacion de n-(4-anilinofenil)metaclilamida
AR223383A1 (es) Procedimiento para la preparacion de 2-isopropilamino-pirimidina
ES497099A0 (es) Procedimiento para la preparacion de sulfonilureas
MX6162E (es) Procedimiento para la preparacion de la 2-isopropilamino-pirimidina
AR229157A1 (es) Procedimiento para la preparacion de 1-(4-hidroxifenil)-2-(4-bencilpiperidino)-1-propanol
ES488859A0 (es) Procedimiento para la preparacion de nuevos dea-esteroides